Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 404.00
Bid: 403.50
Ask: 407.50
Change: 20.50 (5.35%)
Spread: 4.00 (0.991%)
Open: 380.00
High: 407.00
Low: 380.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement Notice of EGM

17 Jun 2019 18:08

RNS Number : 5341C
Banco Santander S.A.
17 June 2019
 

 

 

 

 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

 

RELEVANT INFORMATION

 

The board of directors of Banco Santander, S.A. (the "Bank" or "Santander"), at its meeting held today, resolved to call an extraordinary general shareholders' meeting to be held in Santander, at the Palacio de Exposiciones y Congresos (Avenida del Racing, s/n), on 22 July 2019, at 8:30 a.m., on first call, or on 23 July 2019 at the same time, on second call, with the following agenda:

 

One.- Increases in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance and placement into circulation of new ordinary shares that will be fully subscribed and paid up by means of in-kind contributions, to be used to acquire all of the securities representing the share capital of Banco Santander México, S.A., Institución de Banca Múltiple, Grupo Financiero Santander México ("Santander México") not held by the Santander Group in an exchange offer. The two capital increases would be used to settle the exchange offer in two steps, although only one of them may be implemented if the settlement finally takes place all at once:

 

- Increase in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance and placement into circulation of new ordinary shares having a par value of one-half (0.50) euro each, with a share premium to be determined by the board of directors, or by any of its delegated decision-making bodies or by any director, by delegation therefrom, pursuant to Section 297.1.a) of the Spanish Capital Corporations Law, no later than the date of implementation of the resolution. The new shares will be fully subscribed and paid up by means of in-kind contributions consisting of securities representing the share capital of Santander México, i.e. ordinary series B shares (including those represented through American Depositary Shares (ADSs)) of Santander México, in the form technically and legally appropriate to coordinate the various clearing and settlement systems and the legal provisions applicable in Spain, Mexico and the United States, including, without limitation, the ability to deliver rights to such shares, whether or not represented by certificates (the "Primary Increase"). Express provision for the possibility of incomplete subscription.

 

- Increase in share capital by such amount as may be determined pursuant to the terms of the resolution, by means of the issuance and placement into circulation of new ordinary shares having a par value of one-half (0.50) euro each, with a share premium to be determined by the board of directors, or by any of its delegated decision-making bodies or by any director, by delegation therefrom, pursuant to Section 297.1.a) of the Spanish Capital Corporations Law, no later than the date of implementation of the resolution. The new shares will be fully subscribed and paid up by means of in-kind contributions consisting of securities representing the share capital of Santander México, i.e. ordinary series B shares (including those represented through American Depositary Shares (ADSs)) of Santander México, in the form technically and legally appropriate to coordinate the various clearing and settlement systems and the legal provisions applicable in Spain, Mexico and the United States, including, without limitation, the ability to deliver rights to such shares, whether or not represented by certificates (the "Complementary Increase"). Express provision for the possibility of incomplete subscription.

 

Delegation of powers to the board of directors, which may in turn delegate such powers to any of its delegated decision-making bodies or to any director, to establish the terms and conditions of the increases as to all matters not provided for by the shareholders at the general shareholders' meeting, to take such actions as may be required for implementation hereof, to amend the text of sections 1 and 2 of Article 5 of the Bylaws to reflect the new amount of share capital, and to execute such documents as may be necessary or appropriate to carry out the increases.

Application to the appropriate domestic and foreign authorities for admission to trading of the new shares on the Madrid, Barcelona, Valencia and Bilbao stock exchanges through Spain's Automated Quotation System (Continuous Market) and on the foreign stock exchanges on which the shares of the Bank are listed (currently London, Warsaw and, through ADSs, on the New York Stock Exchange), as well as on the Mexican Stock Exchange, all in the manner required by each of such stock exchanges.

 

Two.- Authorisation to the board of directors to interpret, remedy, supplement, implement and develop the resolutions approved by the shareholders at the meeting, as well as to delegate the powers received from the shareholders at the meeting, and grant of powers to convert such resolutions into notarial instruments.

 

 

The relevant call of meeting will be published in the coming days.

 

 

Boadilla del Monte (Madrid), 17 June 2019 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGBRGDLUGBBGCR
Date   Source Headline
7th May 20247:10 amRNSInvitation to buy outstanding preferred securities
7th May 20247:00 amRNSDirector/PDMR Shareholding
30th Apr 20241:01 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNS1Q 2024 results report & earnings presentation
30th Apr 20247:00 amRNSFirst Quarter 2024 Results - Press release
26th Apr 202411:28 amRNSBuyback programme: transactions 18-25 Apr
23rd Apr 202411:03 amRNSNotice of First Quarter 2024 Results
18th Apr 202411:04 amRNSBuyback programme: transactions 11-17 Apr
11th Apr 202411:07 amRNSBuyback programme: transactions 3-10 Apr
3rd Apr 202411:10 amRNSBuyback programme: transactions 21Mar-2Apr
2nd Apr 20245:07 pmRNSTotal Voting Rights
22nd Mar 20242:27 pmRNS2024 AGM - Resolutions
22nd Mar 20247:00 amRNSSantander is on its track to meet its 2024 targets
21st Mar 202410:52 amRNSBuyback programme: transactions 14-20 Mar
19th Mar 20249:47 amRNS2023 UK Annual Report
18th Mar 20245:46 pmRNSDirector/PDMR Shareholding
18th Mar 20245:37 pmRNSDirector/PDMR Shareholding
18th Mar 20245:26 pmRNSDirector/PDMR Shareholding
14th Mar 202411:04 amRNSBuyback programme: transactions 7-13 Mar
12th Mar 20249:30 amRNSForm 8.3 - Spirent Communications plc
7th Mar 202411:05 amRNSBuyback programme: transactions 29 Feb-6 Mar
29th Feb 20242:50 pmRNSTotal Voting Rights
29th Feb 202411:07 amRNSBuyback programme: transactions 20-28 Feb
27th Feb 20245:15 pmRNSDirector/PDMR Shareholding
27th Feb 20245:13 pmRNSDirector/PDMR Shareholding
27th Feb 20245:12 pmRNSDirector/PDMR Shareholding
21st Feb 20243:33 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSNotice of AGM
19th Feb 202411:17 amRNSDividend approval & buyback program implementation
19th Feb 20247:45 amRNSFurther re dividend approval
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNS2023 Results - Press release
31st Jan 20247:00 amRNS2023 Results Report & Earnings Presentation
26th Jan 202411:32 amRNSCapital reduction following completion of program
26th Jan 202411:19 amRNSTransaction in Own Shares
24th Jan 202411:06 amRNSNotice of 2023 Results Presentation
18th Jan 202411:05 amRNSBuyback programme: transactions 11-17 Jan
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.